SARS-CoV-2 RBD (Omicron/B.1.1.529) protein (Recombinant) (C-Fc) (STJP006920)
SPECIFICATIONS
HostMammalian Cells
ImmunogenSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
General Information
| Short Description | Recombinant-SARS-CoV-2 RBD (Omicron/B.1.1.529)-C-Fc protein was developed from mammalian cells for the region C-Fc. For use in research applications. |
| Applications | ELISA/Immunogen/SDS-PAGE/WB |
| Host | Mammalian Cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Dilution Range | Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details. |
| Formulation | Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| Storage Instruction | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at-20 to-80°C for twelve months from the date of receipt. |
Target Information
| Immunogen | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| Immunogen Region | Arg319-Phe541 (Q493K) |